| |
| |
| Foreword | |
| |
| |
| Preface | |
| |
| |
| Acknowledgements | |
| |
| |
| About the author | |
| |
| |
| |
| Overview | |
| |
| |
| |
| Types of grants | |
| |
| |
| |
| Types of funding organisations | |
| |
| |
| |
| Choosing an appropriate funding body | |
| |
| |
| |
| Contents of the grant application | |
| |
| |
| |
| Including several studies in one application (project grants) | |
| |
| |
| |
| Translational research sub-studies | |
| |
| |
| |
| The application process | |
| |
| |
| |
| Estimating timelines and a planned work schedule | |
| |
| |
| |
| Intellectual property | |
| |
| |
| |
| Text, grammar and format | |
| |
| |
| |
| People involved in the study | |
| |
| |
| |
| Who should be part of the Study Team? | |
| |
| |
| |
| Other investigators, collaborators and consultants | |
| |
| |
| |
| The host institution and Sponsor | |
| |
| |
| |
| Commercial companies | |
| |
| |
| |
| Oversight committees | |
| |
| |
| |
| Justification for the study | |
| |
| |
| |
| Finding background information | |
| |
| |
| |
| Previous evidence and similar research (why the study is needed now) | |
| |
| |
| |
| Biological plausibility | |
| |
| |
| |
| Safety of new interventions in clinical trials | |
| |
| |
| |
| Feasibility | |
| |
| |
| |
| What will the study contribute? | |
| |
| |
| |
| Summary of the justification for a proposed study | |
| |
| |
| |
| Describing the study design | |
| |
| |
| |
| Abstract | |
| |
| |
| |
| Appendices | |
| |
| |
| |
| Study objectives and outcome measures | |
| |
| |
| |
| Types of studies | |
| |
| |
| |
| Observational studies in humans | |
| |
| |
| |
| Clinical trials in humans | |
| |
| |
| |
| Laboratory experiments | |
| |
| |
| |
| Describing sample size | |
| |
| |
| |
| Describing the main statistical analyses | |
| |
| |
| |
| Systematic reviews | |
| |
| |
| |
| Associated documents with the grant application | |
| |
| |
| |
| Study protocol | |
| |
| |
| |
| Participant Information Sheet | |
| |
| |
| |
| Curricula vitae of the Chief Investigator and all co-applicants | |
| |
| |
| |
| Letters of support from co-applicants, centre investigators, collaborators, or other advisors | |
| |
| |
| |
| Letters of support from commercial companies | |
| |
| |
| |
| Other documents specific to the field of research | |
| |
| |
| |
| Financial costs | |
| |
| |
| |
| Overview of items to include in the financial costs | |
| |
| |
| |
| Indirect costs or overheads (full economic costs) | |
| |
| |
| |
| Per patient (or per subject) payments | |
| |
| |
| |
| Staff costs | |
| |
| |
| |
| Access to core funds and resources | |
| |
| |
| |
| Consideration of costs not to be met by the funding body | |
| |
| |
| |
| Grant applications associated with calls for proposals | |
| |
| |
| |
| Observational studies in humans | |
| |
| |
| |
| Clinical trials in humans | |
| |
| |
| |
| Laboratory experiments | |
| |
| |
| |
| Systematic reviews | |
| |
| |
| |
| Funding body review process | |
| |
| |
| |
| Submitting the application | |
| |
| |
| |
| Processing the application within the funding body | |
| |
| |
| |
| Initial reviews (external reviewers) | |
| |
| |
| |
| Funding committee meeting | |
| |
| |
| |
| Funding committee evaluation | |
| |
| |
| |
| Feedback to applicants after the meeting | |
| |
| |
| |
| Responding to the funding committee feedback | |
| |
| |
| |
| Annual reports and applying for a grant extension | |
| |
| |
| |
| Annual reports | |
| |
| |
| |
| Applying for a grant extension | |
| |
| |
| Bibliography | |
| |
| |
| Index | |